Author Correction: Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication

Affiliations

• ¹ Gene Regulation and Translational Medicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
• ² The Inflammation Biology Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
• ³ Medical Genomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
• ⁴ School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia.
• ⁵ Department of Medical Oncology, Monash Health, Clayton, VIC, Australia.
• ⁶ School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
• ⁷ Molecular Parasitology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
• ⁸ Respiratory Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
• ⁹ U955, Equipe 16, Créteil, France.
• ¹⁰ Université Paris-Est Créteil, Faculté de médecine, Créteil, France.
• ¹¹ Vaccine Research Institute (VRI), Créteil, France.
• ¹² INSERM U1184, CEA, IDMIT Department, Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), Université Paris-Saclay, 92265, Fontenay-aux-Roses, France.
• ¹³ Gene Regulation and Translational Medicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. sudha.rao@qimrberghofer.edu.au.